NIH-funded research R01 grant

How interferon proteins affect primate lentiviruses in HIV research models

Official title: Effects of Interferon on primate lentiviruses

Funded at Rockefeller University · NIH-11391010 · Data updated 2026-11-12

This NIH grant studies how natural antiviral interferon proteins influence HIV-like viruses in primate models to better understand infection and disease progression.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 21, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$648,753
NIH project number5R01AI174873-05
Project IDNIH-11391010 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patient participation at this stage; however, future translational work could benefit people living with HIV if findings translate into therapies.

Less likely to help

There is no direct patient involvement in this grant as described.

What this research studies

Researchers will look at how first-line immune proteins called type I interferons restrict lentiviruses that infect primates, using both lab-grown cells and non-human primate models. They will map which interferon-induced genes block virus entry and how different viral envelopes change this effect, aided by a CRISPR screen. The team has already created chimeric viruses that resemble HIV-1 strains found in humans to improve primate studies. The project spans in vitro experiments and in vivo work in non-human primates, with the goal of revealing new points where infections can be blocked.

Why it matters

Potential benefit: Understanding these mechanisms could guide the development of new therapies or preventive strategies against HIV-1 by targeting host factors that control viral entry.

How similar studies have gone: Past work has identified interferon-stimulated genes that affect lentivirus replication and infection, with ongoing exploration of their mechanisms.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Hatziioannou, Theodora — Rockefeller University
  • Study coordinator: Hatziioannou, Theodora

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.